Junhu Zhang

USPTO Granted Patents = 18 (Patent Applications = 5)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 39(Granted Patents)

Company Filing History:

6 out of 2,405

Merck Sharp + Dohme Corp.

Agouron Pharmaceuticals, Inc.

patents

4. 4 out of 1,571

Lawrence Livermore National Security, LLC

Trius Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12410179 - Modulators of TNF alpha activity and uses thereof (2025-09-09),

2. 11230524 - Myocyte enhancer factor 2 (MEF2) modulators (2022-01-25),

3. 10865216 - Tricyclic Gyrase inhibitors (2020-12-15),

4. 10858360 - Tricyclic gyrase inhibitors (2020-12-08),

5. 10385055 - Tricyclic gyrase inhibitors (2019-08-20),

6. 10047105 - Gyrase inhibitors (2018-08-14),

7. 9732083 - Tricyclic gyrase inhibitors (2017-08-15),

8. 9481675 - Gyrase inhibitors (2016-11-01),

9. 8835445 - Dihydrofolate reductase inhibitors (2014-09-16),

10. 8598184 - Protein kinase inhibitors (2013-12-03),

11. 8530652 - Pyrrolopyrazoles, potent kinase inhibitors (2013-09-10),

12. 8067591 - Pyrrolopyrazole, potent kinase inhibitors (2011-11-29),

13. 7692014 - Inhibitors of the HIV integrase enzyme (2010-04-06),

14. 7468375 - Inhibitors of the HIV integrase enzyme (2008-12-23),

15. 7368571 - HIV-Integrase inhibitors, pharmaceutical compositions and methods for their use (2008-05-06),

Title: The Innovative Contributions of Junhu Zhang

Introduction

Junhu Zhang is a prominent inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate various biological activities. With a total of 18 patents to his name, Zhang's work has the potential to impact the treatment of several diseases.

Latest Patents

Among his latest patents are "Modulators of TNF alpha activity and uses thereof," which describes modulators of TNF alpha activity and pharmaceutical compositions comprising said inhibitors. These compounds and compositions are useful for the treatment of TNF alpha-mediated disorders or diseases. Another notable patent is for "Myocyte enhancer factor 2 (MEF2) modulators," which provides novel compounds capable of functioning as MEF2 modulators, along with compositions, pharmaceutical formulations, methods of synthesis, and kits.

Career Highlights

Zhang has worked with leading companies in the pharmaceutical industry, including Pfizer Corporation and Agouron Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.

Collaborations

Zhang has collaborated with notable colleagues such as Zhiyong Chen and Thanh To Lam. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Junhu Zhang's innovative work and extensive patent portfolio highlight his significant contributions to the pharmaceutical field. His research continues to pave the way for new treatments and therapies that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.